Combination treatment with sofosbuvir and ribavirin for patients diagnosed with hepatitis C genotype 2: A real-world, single-center study
Authors:
- 1 March 2021
- journal article
- research article
- Published by Elsevier in Arab Journal of Gastroenterology
- Vol. 22 (1) , 23-27
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virusHepatology, 2015
- Concordance of sustained virological response 4, 12, and 24 weeks post‐treatment with sofosbuvir‐containing regimens for hepatitis C virusHepatology, 2014
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3New England Journal of Medicine, 2014
- A nationwide seroepidemiology of hepatitis C virus infection in South KoreaLiver International, 2013
- Transmission of Hepatitis C Virus Infection Through Tattooing and Piercing: A Critical ReviewClinical Infectious Diseases, 2012
- Hepatitis C virus (HCV) genotypes and the influence of HCV subtype 1b on the progression of chronic hepatitis C in Korea: a single center experienceClinical and Molecular Hepatology, 2012
- Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver diseaseGut, 2010
- HCV infection facilitates asymptomatic carotid atherosclerosis: preliminary report of HCV RNA localization in human carotid plaquesDigestive and Liver Disease, 2007
- Current Status of Hepatitis C Virus Infection in KoreaIntervirology, 2005
- Changes in haemoglobin during interferon alpha‐2b plus ribavirin combination therapy for chronic hepatitis C virus infectionJournal of Viral Hepatitis, 2004